BioCentury | Nov 30, 2018
Targets & Mechanisms

Adhesion targets emerge at ASH 2018

...ubiquitin like modifier activating enzyme 1 (UBA1; UBE1) inhibitors in AML. University of Toronto 1350 G protein-coupled receptor family C group 5 member D (GPRC5D)...
BioCentury | Dec 20, 2012
Distillery Therapeutics

Indication: Endocrine/metabolic disease

This week in therapeutics Indication Target/marker/pathway Summary Licensing status Publication and contact information Endocrine/metabolic disease Diabetes; obesity G protein-coupled receptor family C group 5 member B (GPRC5B) Mouse studies suggest inhibiting GPRC5B could help treat...
BioCentury | Apr 14, 2011

sanofi rolls the bones

sanofi-aventis Group has seized an early stage opportunity that opened up when Biogen Idec Inc. recently refocused on neurology, by picking up an obesity and type 2 diabetes program centered on osteocalcin that was previously...
Items per page:
1 - 3 of 3